Karen Marie Walker
Chief Technology Officer · Kyverna Therapeutics, Inc.
IndividualSelling only3 10b5-1 trades
- 2025
- Dec 18, 2025
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Karen Marie Walker's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Matthew Rabinowitz - $124.05M in NTRA purchases and sales in the last 12 months
- BAKER BROS. ADVISORS LP - $118.63M in KOD purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $117.62M in ARTV purchases and sales in the last 12 months
- SVF Pauling (Cayman) Ltd - $116.40M in RLAY purchases and sales in the last 12 months
- Bain Capital Life Sciences Investors, LLC - $115.00M in HTFL purchases and sales in the last 12 months
- Michael Simanovsky - $110.65M in SNDA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Karen Marie Walker?
Karen Marie Walker is a corporate insider, tracked as Chief Technology Officer of Kyverna Therapeutics, Inc. (KYTX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Karen Marie Walker last file a Form 4?
The only primary Form 4 on record is dated 18 December 2025.
Has Karen Marie Walker been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($293K) across all tracked filings.
